Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-23
DOI
10.3389/fphar.2018.00542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism
- (2016) Daniel M. Witt et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- National Trends in Ambulatory Oral Anticoagulant Use
- (2015) Geoffrey D. Barnes et al. AMERICAN JOURNAL OF MEDICINE
- Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration
- (2015) Paulo Caleb Junior Lima Santos et al. PHARMACOGENOMICS
- New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
- (2015) Rick van Gorp et al. Nutrients
- Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 Genes and the Therapeutic Warfarin Dose in Brazilian Patients with Thrombosis: A Prospective Cohort Study
- (2014) Vanessa Cristina de Oliveira Almeida et al. Molecular Diagnosis & Therapy
- C3435T polymorphism of MDR1 gene with warfarin resistance
- (2013) Yeongsic Kim et al. CLINICA CHIMICA ACTA
- Pharmacogenetics of warfarin: challenges and opportunities
- (2013) Ming Ta Michael Lee et al. JOURNAL OF HUMAN GENETICS
- Is There a Role for MDR1, EPHX1 and Protein Z Gene Variants in Modulation of Warfarin Dosage? A Study on a Cohort of the Egyptian Population
- (2013) Marianne Samir Makboul Issac et al. Molecular Diagnosis & Therapy
- Evidence-Based Management of Anticoagulant Therapy
- (2012) Anne Holbrook et al. CHEST
- CYP2C9 and VKORC1 Polymorphisms Are Differently Distributed in the Brazilian Population According to Self-Declared Ethnicity or Genetic Ancestry
- (2012) Renata Alonso Gadi Soares et al. Genetic Testing and Molecular Biomarkers
- A new algorithm to predict warfarin dose from polymorphisms of CYP4F2, CYP2C9 and VKORC1 and clinical variables: Derivation in Han Chinese patients with non valvular atrial fibrillation
- (2012) Meng Wei et al. THROMBOSIS AND HAEMOSTASIS
- CYP2C19 and ABCB1gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
- (2011) Paulo CJL Santos et al. BMC Medical Genetics
- Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry
- (2011) Mariana Rodrigues Botton et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000® instrument
- (2011) Paulo Caleb Junior Lima Santos et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Pharmacogenomics: Application to the Management of Cardiovascular Disease
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of the C3435T polymorphism of the MDR1 gene and therapeutic doses of warfarin in thrombophilic patients
- (2011) V. C. DE OLIVEIRA ALMEIDA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected
- (2011) Sérgio D. J. Pena et al. PLoS One
- CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
- (2010) Han-Jing Cen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of CYP4F2 rs2108622 on the Stable Warfarin Dose in an Admixed Patient Cohort
- (2010) J A Perini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCB1 single nucleotide polymorphisms in the Brazilian population
- (2009) Marcos Antonio Mauricio Scheiner et al. MOLECULAR BIOLOGY REPORTS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy
- (2009) Jieying Eunice Zhang et al. Pharmacogenetics and Genomics
- CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population
- (2009) Paola Borgiani et al. PHARMACOGENOMICS
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
- (2008) G. M. Cooper et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started